LAVA Therapeutics NV (LVTX)
3.03
-0.07
(-2.26%)
USD |
NASDAQ |
May 03, 16:00
3.05
+0.02
(+0.66%)
After-Hours: 20:00
LAVA Therapeutics 1 Year Total Returns (Daily): 100.7% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 03, 2024 | 100.7% |
| May 02, 2024 | 104.6% |
| May 01, 2024 | 96.69% |
| April 30, 2024 | 91.39% |
| April 29, 2024 | 92.05% |
| April 26, 2024 | 80.79% |
| April 25, 2024 | 65.00% |
| April 24, 2024 | 71.25% |
| April 23, 2024 | 82.82% |
| April 22, 2024 | 74.85% |
| April 19, 2024 | 64.24% |
| April 18, 2024 | 69.46% |
| April 17, 2024 | 54.74% |
| April 16, 2024 | 62.36% |
| April 15, 2024 | 64.61% |
| April 12, 2024 | 101.9% |
| April 11, 2024 | 136.9% |
| April 10, 2024 | 117.1% |
| April 09, 2024 | 89.51% |
| April 08, 2024 | 106.3% |
| April 05, 2024 | 102.0% |
| April 04, 2024 | 80.50% |
| April 03, 2024 | 100.6% |
| April 02, 2024 | 87.95% |
| April 01, 2024 | 103.0% |
| Date | Value |
|---|---|
| March 28, 2024 | 105.6% |
| March 27, 2024 | 145.9% |
| March 26, 2024 | 153.5% |
| March 25, 2024 | 133.3% |
| March 22, 2024 | 122.6% |
| March 21, 2024 | 92.31% |
| March 20, 2024 | 91.88% |
| March 19, 2024 | 92.17% |
| March 18, 2024 | 77.11% |
| March 15, 2024 | 71.51% |
| March 14, 2024 | 50.55% |
| March 13, 2024 | 49.72% |
| March 12, 2024 | 24.12% |
| March 11, 2024 | 27.64% |
| March 08, 2024 | 2.65% |
| March 07, 2024 | 10.26% |
| March 06, 2024 | -4.26% |
| March 05, 2024 | -7.79% |
| March 04, 2024 | 24.18% |
| March 01, 2024 | -1.35% |
| February 29, 2024 | 48.66% |
| February 28, 2024 | -3.57% |
| February 27, 2024 | -3.64% |
| February 26, 2024 | -1.09% |
| February 23, 2024 | -12.29% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-79.39%
Minimum
Jun 17 2022
153.5%
Maximum
Mar 26 2024
-38.87%
Average
-51.24%
Median
1 Year Total Returns (Daily) Benchmarks
| uniQure NV | -77.38% |
| ProQR Therapeutics NV | -9.05% |
| Merus NV | 155.5% |
| argenx SE | -1.04% |
| Pharming Group | -10.31% |